Akebia Therapeutics AKBA spent $310K on lobbying in Q4 2022 · Health Issues, Medicare

Trade details

Type: Lobbying report
Amount: $310,000
Quarter: Q4 2022
Stock: Akebia Therapeutics AKBA
Client: Akebia Therapeutics
Reported: 23/01/20

$370K on lobbying in 2022

What else happened in Akebia Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/01~23/01/30

Akebia Therapeutics's other lobbying reports

Akebia Therapeutics
LobbyingAkebia Therapeutics
Lobbying
Akebia Therapeutics
AKBA
$360K
$360K
Reported 07/20
for Q2
Akebia Therapeutics
LobbyingAkebia Therapeutics
Lobbying
Akebia Therapeutics
AKBA
$60K
$60K
Reported 07/20
for Q2
Akebia Therapeutics
LobbyingAkebia Therapeutics
Lobbying
Akebia Therapeutics
AKBA
$60K
$60K
Reported 07/13
for Q2
Akebia Therapeutics
LobbyingAkebia Therapeutics
Lobbying
Akebia Therapeutics
AKBA
$480K
$480K
Reported 04/20
for Q1
Akebia Therapeutics
LobbyingAkebia Therapeutics
Lobbying
Akebia Therapeutics
AKBA
$60K
$60K
Reported 04/20
for Q1